Mahana Tinnitus Pilot
- Conditions
- Tinnitus
- Interventions
- Device: MHNA-003
- Registration Number
- NCT05696158
- Lead Sponsor
- Mahana Therapeutics
- Brief Summary
The main objective of this prospective, open-label, non-significant risk study is to assess the efficacy and safety of Mahana™ Tinnitus together with care as usual in approximately 250 adults with symptoms of tinnitus.
- Detailed Description
Following informed consent, all participants will complete a series of screening questionnaires to determine eligibility for study entry. Eligible participants will be enrolled, and will receive access to MHNA-003 (Mahana™ Tinnitus). Participants will use MHNA-003 for 6 weeks, completing assessments at Baseline and Weeks 2, 4, and 6 following Baseline.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 97
- Participant scores ≥ 25 on the Tinnitus Functional Index.
- Participant has experienced symptoms of tinnitus for at least 3 months.
- Participant is at least 18 years of age at the time of consent.
- Participant resides in the United States.
- Participant is able to speak, read, and understand English.
- Participant has access to an iOS or Android smartphone with the ability to complete study tasks.
- Participant is able to commit the time required to complete therapy modules and study assessments.
- Participant scores ≥2 on item 9 (suicidal thoughts) of the Beck's Depression Index (BDI).
- Participant has been hospitalized for psychiatric reasons within 12 months of screening.
- Participant is currently enrolled in or plans to enroll in another clinical study that could impact outcomes of this trial.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description MHNA-003 MHNA-003 MHNA-003 is a self-guided digital program for people living with tinnitus
- Primary Outcome Measures
Name Time Method Mean Change in TFI Score From Baseline to Week 6 6 weeks The Tinnitus Functional Index (TFI) is a validated, 25-item questionnaire designed to measure the severity and negative impact of tinnitus. Total scores range from 0-100 with higher scores representing higher severity and more negative impact. An improvement of 13 or more points is considered a clinically meaningful change.
Tinnitus Functional Index Responder Rate 6 weeks The Tinnitus Functional Index (TFI) is a validated, 25-item questionnaire designed to measure the severity and negative impact of tinnitus. Total scores range from 0-100 with higher scores representing higher severity and more negative impact. A responder is defined as a participant who experienced an improvement of 13 or more points from baseline to Week 6. The responder rate is the percentage of participants considered responders at Week 6.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Mahana Therapeutics
🇺🇸San Francisco, California, United States